ArticleAnnals of medicine and surgery (2012)2020

Pembrolizumab plus platinum-based chemotherapy for unfavorable cancer of unknown primary site: Case report.

Teppei Kamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.